Legal Opinion
Sun Pharmaceutical Industries, Ltd. v. Eli Lilly & Co.
Court of Appeals for the Federal Circuit
Decided July 28, 2010No. 2010-1105PublishedCited by 17 opinions
1Opinion of the Court
PROST, Circuit Judge.
Appellant Eli Lilly and Company (“Lilly”) appeals from a final judgment of the U.S. District Court for the Eastern District of Michigan, finding claims 2, 6, and 7 of U.S. Patent No. 5,464,826 (“'826 patent”) invalid for obviousness-type double patenting over U.S. Patent No. 4,808,614 (“'614 patent”). Because the district court correctly found these claims of the '826 patent invalid, we affirm.
Background
Lilly markets the drug Gemzar® for the treatment of various forms of cancer. The active ingredient in Gemzar® is gemcitabine. Both patents at issue in this suit, the '614…
2Cases cited10 opinions
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- Nicholas v. Perricone, M.D. v. Medicis Pharmaceutical Corporation, Defendant-CrossCourt of Appeals for the Federal Circuit · 2005
- ICU Medical, Inc. v. Alaris Medical Systems, Inc.Court of Appeals for the Federal Circuit · 2009
- Aquatex Industries, Inc. v. Techniche SolutionsCourt of Appeals for the Federal Circuit · 2005
- Pfizer, Inc. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2008
5 more not listed; retrieve them via the Exa API.
3Cited by17 opinions
- Bayer Healthcare Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 2013
- AbbVie Inc. v. Mathilda & Terrance Kennedy Institute of Rheumatology TrustCourt of Appeals for the Federal Circuit · 2014
- Eli Lilly and Co. v. Teva Parenteral Medicines, Inc.Court of Appeals for the Federal Circuit · 2012
- Ucb, Inc. v. Accord Healthcare, Inc.Court of Appeals for the Federal Circuit · 2018
- Sun Pharmaceutical Industries, Ltd. v. Eli Lilly & Co.Court of Appeals for the Federal Circuit · 2010
12 more not listed; retrieve them via the Exa API.